Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Flower One is the largest cannabis cultivator, producer and full-service brand fulfillment partner in the state of Nevada. Flower One's fully operational flagship 400,000 square-foot greenhouse and 55,000 square-foot production facility is used for cannabis cultivation, processing, production and manufacturing of dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals and infused products. The Company also operates a 25,000 square-foot indoor cultivation and production facility in North Las Vegas, with nine grow rooms, and a state of the art commercial kitchen that will produce several of the industry’s top performing edible brands. Leveraging its scale and more than 20 years of greenhouse operational excellence, Flower One offers consistent, reliable, high-volume, and just-in-time fulfillment to a growing number of established cannabis brands. The Company is fully licensed for both recreational and medical marijuana cultivation and production in the state of Nevada.

FSD Pharma Inc. is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative and inflammatory disorders. The three licensed drug candidates are LUCID-MS, a new chemical entity targeting Multiple Sclerosis, LUCID-PSYCH, a psychoactive molecule targeting Major Depressive Disorder, and FSD-PEA, an ultra-micronized Palmitoyl ethylamine with a favorable safety profile targeting inflammation.


GABY Inc. is a publicly traded cannabis company, listed on the CSE and OTCQB. By the end of 2022, the company plans to expand to additional retail locations, eventually becoming a dominant player in the California market.

The company’s flagship Mankind Dispensary serves nearly 30,000 shoppers per month, has a robust delivery and curbside pickup program, and stocks more than 700 unique products at any time, including GABY’s Kind Republic flower, prerolls, and extracts.

GABY’s leadership team of retail and cannabis experts curate industry-leading experiences which celebrate cannabis culture, and introduces customers to some of the best cannabis in the world.

By operating an expanding portfolio of brands and dispensaries, GABY is building a consumer-focused ecosystem that keeps shoppers happy, prices accessible, and builds lifelong connections between brands and their consumers.

Gaia Grow Corp. (the “Company”) is a licenced cultivator of industrial hemp. The Company’s business model leverages contract farming to utilize existing farmland and skilled farmers to cultivate industrial hemp, which it then sells to processors to be turned into hemp fibre and cannabidiol oil and concentrates. The Company expects to expand its operations to include retail cannabis stores in British Columbia.

Gemina Labs is a biosensor and diagnostic company with a unique and transformative proprietary biochemistry that significantly improves the performance of human and animal testings, including COVID-19, Influenza and other viruses.

GeneTether Therapeutics is an innovative genetic medicines company focused on creating best-in-class gene editing therapies based on our proprietary GeneTether™ platform. Our platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs. We use a proprietary method to “tether” donor DNA templates to the genome editing complex, making the template readily available for use during the genome editing repair stage.

Global Health Clinics operates a two-part system of customer lead generation and conversion, through its network of pavilions and the ownership and operation of five medical clinics that aim to connect Canadians with ACMPR license producers by advancing the understanding of medical cannabis and its applications, and the provision of related services and products for patients suffering from illness from which they may find relief with medical cannabis, including facilitating access to qualified health care practitioners, independent medical cannabis evaluations and related advice. Through its pavilions, the company is developing a substantive consumer database of persons interested in both medicinal and recreational use

Vodis Pharmaceuticals Inc. is a craft cannabis producer in Delta, British Columbia, Canada.  The company was issued a Standard Cultivation licence and Standard Processing licence under the Cannabis Act on January 31, 2020.  The company operates a 12,000 sqft indoor facility growing proprietary cultivars for the adult-use, recreational cannabis market.  At full capacity, the Delta facility will yield approximately 1,500 kg of craft cannabis annually.  

Goodness Growth is a United States-based multi-state cannabis company with significant operations in our three core markets of Maryland, Minnesota, and New York. We are science-focused and dedicated to providing patients and adult-use customers with high quality cannabis-based products. We cultivate cannabis in environmentally friendly greenhouses, manufacture pharmaceutical-grade cannabis extracts, and sell our products at both Company-owned and third-party dispensaries to qualifying patients and adult-use customers. We currently serve thousands of customers each month.

In addition to the listed Subordinate Voting Shares, there are 348,642 Multiple Voting Shares issued and outstanding. Each Multiple Voting Share is convertible into 100 Subordinate Voting Shares at the option of the holder or upon certain triggering events. This number also includes Subordinate Voting Shares underlying existing and proposed convertible securities.


Green Scientific Labs Holdings Inc. is a leading cannabis and hemp testing laboratory that currently operates one testing lab facility in Florida which provides analytical testing services for state licensed cannabis and hemp growers, product formulators, processors, distributors and retailers. GSL provides industry-leading analysis and testing to the cannabis and hemp industry, under ISO-17025:2017 guidelines, to ensure consumers know in the composition of cannabis and hemp they ingest and to help maximize the quality of its client’s products through research, development and standardization.

Contact The Team

How can we help you?

Contact the CSE team to find out more.